Cargando...

Immune checkpoint inhibitors in genitourinary malignancies

Although immune-mediated therapies have been used in genitourinary (gu) malignancies for decades, recent advances with monoclonal antibody checkpoint inhibitors (cpis) have led to a number of promising treatment options. In renal cell carcinoma (rcc), cpis have been shown to have benefit over conven...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Curr Oncol
Main Authors: Thana, M., Wood, L.
Formato: Artigo
Idioma:Inglês
Publicado: Multimed Inc. 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7194001/
https://ncbi.nlm.nih.gov/pubmed/32368176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.5121
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!